AASLD The Liver Meeting® 2020: Antaros Medical presents data on non-invasive MRI prediction of NASH and advanced liver fibrosis in patients with NAFLD

November 14th, 2020

Antaros Medical, in collaboration with Boehringer Ingelheim and Uppsala University, are presenting brand new data from our liver imaging method study AM-02 at this year’s AASLD TLMdX. The data is giving novel insights on the value of Magnetic Resonance Imaging (MRI) in non-alcoholic fatty liver disease (NAFLD).


NAFLD affects around 25-30% of the adult population worldwide. The disease is associated with an increased risk of advanced fibrosis, cirrhosis, and liver-related mortality. It is crucial to understand disease progression and severity for both clinical management and clinical research. Today, liver biopsy is used for disease stratification but is limited by cost and risks. MRI biomarkers have emerged as key non-invasive alternatives to accurately detect hepatic steatosis and liver fibrosis and could potentially also be used to identify the progressive form of non-alcoholic steatohepatitis (NASH).


The results from our liver imaging method study further underline the value of MRI in NAFLD. They show that MR-based biomarkers predict both NASH and advanced fibrosis in this patient population. To read more about our results, visit the following posters/abstracts presented at this year’s AASLD the Liver Meeting (TLMdX).


Bivariate MR Imaging biomarker to improve prediction of advanced fibrosis in subjects with biopsy proven NAFLD

Authors: P Hockings, E Johansson, J Vessby, A Gummesson, K Heurling, A Frödén Löwenmark, O Eriksson, C Roberts, L Johansson, A Hedström, J Hulthe, C Schultheis, C Schoelch, H Niessen, M Lubberink, A Wanders, F Rorsman and H Ahlström

Publication number: 1486


Non-invasive imaging biomarkers to detect NASH in subjects with NAFLD

Authors: J Vessby, P Hockings, A Gummesson, E Johansson, K Heurling, A Frödén Löwenmark, O Eriksson, L Johansson, C Roberts, A Hedström, C Schultheis, C Schoelch, H Niessen, J Hulthe, M Lubberink, H Ahlström, F Rorsman and A Wanders

Publication number: 1535


Back to all news